Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas-Reference-Cited by-同舟云学术

Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas

Published:2017-09-25 Issue:1 Volume:65 Page:e26784
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Yeh E. Ann¹,Greenberg Jay²,Abla Oussama³,Longoni Giulia¹,Diamond Eli⁴,Hermiston Michelle⁵,Tran Brandon⁶,Rodriguez-Galindo Carlos⁷^ORCID,Allen Carl E.⁸,McClain Kenneth L.⁸^ORCID,

Affiliation:

1. Department of Neurology; The Hospital for Sick Children; Toronto Ontario Canada

2. Center for Cancer and Blood Disorders; Children's National Medical Center; Washington District of Columbia

3. Division of Haematology/Oncology; Department of Paediatrics; The Hospital for Sick Children; Toronto Ontario Canada

4. Department of Neurology; Memorial Sloan Kettering Cancer Center; New York New York

5. Department of Pediatric Oncology; UCSF Medical Center-Mission Bay; San Francisco California

6. Department of Radiology; Baylor College of Medicine; Houston Texas

7. Department of Pediatrics; St. Jude Children's Research Hospital; Memphis Tennessee

8. Department of Pediatrics; Texas Children's Cancer and Hematology Centers and Baylor College of Medicine; Houston Texas

Funder

St. Baldrick's Foundation

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference81 articles.

1. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease;Willman;N Engl J Med,1994

2. Recurrent BRAF mutations in Langerhans cell histiocytosis;Badalian-Very;Blood.,2010

3. Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis;Chakraborty;Blood.,2016

4. Genomic alterations in Langerhans cell histiocytosis;Rollins;Hematol Oncol Clin North Am,2015

5. Braf-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups;Berres;J Exp Med,2014

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium;Blood Neoplasia;2024-09

2. A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study;Frontiers in Immunology;2024-08-16

3. Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications;Endocrine Reviews;2024-07-26

4. Histiocitosis de células de Langerhans;EMC - Pediatría;2024-06

5. Differential Gene Analysis of Langerhans Cell Histiocytosis and the Significance of MMP1-Targeted Drug Repositioning;Molecular Biotechnology;2024-05-15